Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,971 | -180,091 | -128,518 | -92,879 | -53,867 |
| Depreciation Amortization | 7,092 | 25,996 | 28,923 | 18,216 | 8,988 |
| Accounts receivable | 1,241 | 853 | 2,577 | 4,056 | 2,851 |
| Accounts payable and accrued liabilities | -4,606 | 2,467 | -4,325 | -632 | 5,043 |
| Other Working Capital | -11,322 | 80,775 | 64,805 | 28,799 | 1,646 |
| Other Operating Activity | 28,246 | 55,208 | 48,623 | 22,462 | 8,865 |
| Operating Cash Flow | $-55,320 | $-14,792 | $12,085 | $-19,978 | $-26,474 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 38,432 | -113,472 | -126,042 | -163,936 | -96,436 |
| PPE Investments | -131 | -5,101 | -4,947 | -4,598 | -4,495 |
| Purchase Sale Intangibles | -5,136 | -19,050 | -14,004 | -8,979 | -4,775 |
| Other Investing Activity | -5,136 | -19,050 | -14,004 | -8,979 | -4,775 |
| Investing Cash Flow | $33,165 | $-137,623 | $-144,993 | $-177,513 | $-105,706 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 104,926 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 19,667 | 237,775 | 200,835 | 197,230 | 197,010 |
| Other Financing Activity | -10,680 | -6,092 | -2,365 | -1,174 | -1,257 |
| Financing Cash Flow | $113,913 | $231,683 | $198,470 | $196,056 | $195,753 |
| Exchange Rate Effect | -939 | 1,713 | -7 | -49 | -113 |
| Beginning Cash Position | 165,753 | 84,772 | 84,772 | 84,772 | 84,772 |
| End Cash Position | 256,572 | 165,753 | 150,327 | 83,288 | 148,232 |
| Net Cash Flow | $90,819 | $80,981 | $65,555 | $-1,484 | $63,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,320 | -14,792 | 12,085 | -19,978 | -26,474 |
| Capital Expenditure | -131 | -5,101 | -4,947 | -4,598 | -4,495 |
| Free Cash Flow | -55,451 | -19,893 | 7,138 | -24,576 | -30,969 |